JACQUELYN ZAGONE: Open Payments
NPI 1003500513 · WENONAH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 52 payments from 14 companies in 2025. Trend: 2023 $17 · 2024 $1,226 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 12 | $223 |
| Alkermes, Inc. | 7 | $191 |
| E.R. Squibb & Sons, L.L.C. | 5 | $94 |
| ABBVIE INC. | 5 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| Supernus Pharmaceuticals, Inc. | 3 | $52 |
| Bausch Health US, LLC | 2 | $39 |
| Indivior Inc. | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
Products named: Auvelity, LYBALVI, COBENFY, VRAYLAR, CAPLYTA, REXULTI, Qelbree, APLENZIN.
Industry payments across NJ — which companies pay providers there.
